Prostate Cancer News You Can Use from Us TOO provides some of the latest news articles on prostate cancer and is distributed via email each month at no charge.
PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U.S. by year end
TAIPEI, May 26, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug
The following information was released by the Cleveland Clinic: Content is property of Cleveland Clinic and for news media use only. According to new findings published in Science
Chicago [US], May 23 (ANI): According to a new study by University of Illinois Chicago researchers, environmental quality is associated with advanced-stage prostate cancer at
2021 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Daily News -- During the first wave of the corona pandemic, 36 per cent fewer men were diagnosed with
CLEVELAND, Ohio, April 23 (TNSRes) -- Case Western Reserve University issued the following news release:The U.S. Food and Drug Administration has approved human clinical trials to
2021 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Education Daily Report -- Tumor gene profiling is a tool that can help patients with a cancer diagnosis make
Men undergoing surgery for prostate cancer may no longer have to live with erectile dysfunction afterward, thanks to an innovative new treatment, researchers said in a paper
2021 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Drug Daily -- Bottom Line: Various genetic alterations in circulating tumor cells (CTCs) were associated with
WASHINGTON, April 7 -- The U.S. Army Medical Research Acquisition Activity announced that it expects to award up to 30 grants or cooperative agreements for prostate cancer research
Receive emails from Us TOO including the HotSheet e-newsletter and the latest Prostate Cancer News You Can Use each month.